These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1336768)

  • 1. Drug addict rehabilitation: a burden on society?
    Berg JE; Andersen S
    Int J Rehabil Res; 1992; 15(4):301-9. PubMed ID: 1336768
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychotropic drug use and expenditures among medicaid beneficiaries with and without other mental health or substance abuse services.
    Hennessy KD; Green-Hennessy S; Buck JA; Miller K
    J Nerv Ment Dis; 2003 Jul; 191(7):476-8. PubMed ID: 12891096
    [No Abstract]   [Full Text] [Related]  

  • 3. [Assessment of cost-benefit analysis in integration projects on drug addiction].
    Ates T; Langer B; Erbas B; Tretter F; Wehner B
    Gesundheitswesen; 2005 Feb; 67(2):159-62. PubMed ID: 15747208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the economic cost of substance abuse treatment.
    French MT; McGeary KA
    Health Econ; 1997; 6(5):539-44. PubMed ID: 9353658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of family-based substance abuse treatment.
    Morgan TB; Crane DR
    J Marital Fam Ther; 2010 Oct; 36(4):486-98. PubMed ID: 21039660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic costs of drug abuse: financial, cost of illness, and services.
    Cartwright WS
    J Subst Abuse Treat; 2008 Mar; 34(2):224-33. PubMed ID: 17596904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of substance abuse treatment modality on birth weight and health care expenditures.
    Daley M; Argeriou M; McCarty D; Callahan JJ; Shepard DS; Williams CN
    J Psychoactive Drugs; 2001; 33(1):57-66. PubMed ID: 11333002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of reforms on spending for veterans' substance abuse treatment, 1993-1999.
    Chen S; Wagner TH; Barnett PG
    Health Aff (Millwood); 2001; 20(4):169-75. PubMed ID: 11463073
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic cost of illicit drug studies: critique and research agenda.
    Sindelar JL
    NIDA Res Monogr; 1991; 113():33-45. PubMed ID: 1762641
    [No Abstract]   [Full Text] [Related]  

  • 11. Costs of alcohol and drug abuse in the United States, 1992. Alcohol/Drugs COI Study Team.
    Holland P; Mushinski M
    Stat Bull Metrop Insur Co; 1999; 80(4):2-9. PubMed ID: 10553265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sensitivity of substance abuse treatment intensity to co-payment levels.
    Lo Sasso AT; Lyons JS
    J Behav Health Serv Res; 2004; 31(1):50-65. PubMed ID: 14722480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conceptual framework for estimating the social cost of drug abuse.
    French MT; Rachal JV; Hubbard RL
    J Health Soc Policy; 1991; 2(3):1-22. PubMed ID: 10170913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of statistical models to predict mental health and substance abuse cost.
    Montez-Rath M; Christiansen CL; Ettner SL; Loveland S; Rosen AK
    BMC Med Res Methodol; 2006 Oct; 6():53. PubMed ID: 17067394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?
    Dismuke CE; French MT; Salomé HJ; Foss MA; Scott CK; Dennis ML
    J Subst Abuse Treat; 2004 Oct; 27(3):253-63. PubMed ID: 15501378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic costs of drug abuse.
    Rice DP; Kelman S; Miller LS
    NIDA Res Monogr; 1991; 113():10-32. PubMed ID: 1762634
    [No Abstract]   [Full Text] [Related]  

  • 17. Socioeconomic analysis of addictions treatment.
    Langenbucher JW
    Public Health Rep; 1996; 111(2):135-7. PubMed ID: 8606910
    [No Abstract]   [Full Text] [Related]  

  • 18. Mental health parity legislation, cost-sharing and substance-abuse treatment admissions.
    Dave D; Mukerjee S
    Health Econ; 2011 Feb; 20(2):161-83. PubMed ID: 20029912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization, costs of substance abuse growing, researchers warn.
    Capitation Rates Data; 2002 Jan; 7(1):10-2. PubMed ID: 11828804
    [No Abstract]   [Full Text] [Related]  

  • 20. Substance abuse treatment: outcomes of managed care techniques.
    Chung R; Filstead WJ
    Behav Healthc Tomorrow; 1995; 4(6):78-9, 58. PubMed ID: 10172617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.